Decrease of tyrosine hydroxylase-, α-synuclein- and parkin-expressing neurons in the substantia nigra of MPTP-treated C57BL/6N mice

Biogenic Amines

Volumn 16, Issue 2, 2001, Pages 127-136

  Kitamura, Y ^a   Sanada, H ^a   Kakimura, J ^a   Ishida, Y ^a   Shimohama, S ^a   Taniguchi, T ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

synuclein; C57BL 6N mouse; MPTP; Parkin; Substantia nigra; Tyrosine hydroxylase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA SYNUCLEIN; SYNUCLEIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; GENE MUTATION; IMMUNOREACTIVITY; MALE; MOUSE; MOUSE STRAIN; NERVE CELL; NERVE DEGENERATION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SUBSTANTIA NIGRA;

EID: 0034993102     PISSN: 01688561     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. The synucleins in synaptic plasticity and neurodegenerative disorders
2. Chronic Parkinsonism secondary to intravenous injection of meperidine analogues
3. Protects for new restorative and neuroprotective treatments in Parkinson's disease
4. Cloning of rat parkin cDNA and distribution of parkin in rat brain
5. Alpha-synuclein in Lewy body disease and Alzheimer's disease
6. The cDNA cloning and ontogeny of mouse α-synuclein
7. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease
8. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system
9. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
10. Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL/6 mice
11. Inhibitory effects of talipexole and pramipexole on MPTP-induced dopamine reduction in the striatum of C57BL/6N mice
12. MPTP toxicity: Implications for research in Parkinson's disease
13. MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons
14. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease
15. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis
16. MPTP: Current concepts and controversies
17. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure
18. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease
19. Etiology and pathogenesis of Parkinson's disease
20. Mutation in the α-synuclein gene identified in families with Parkinson's disease
21. Immunohistochemical and subcellular localization of parkin protein: Absence of protein in autosomal recessive juvenile parkinsonism patients
22. Familial parkinson disease gene product, parkin, is a ubiquitin-protein ligase
23. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies
24. Evidence for generation of oxidative stress in brain by MPTP: In vitro and in vivo studies in mice
25. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining
26. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease